Novartis CEO-Designate Set To Bring More Automation To Drug Discovery

 
• By Sten Stovall

Vasant Narasimhan, who is replacing Joseph Jimenez as Novartis' CEO next year, is an advocate of automation and artificial intelligence in future drug discovery.

Relay
Novartis CEO Joe Jimenez Will Hand Over To Vas Narasimhan On Feb 1, 2018 • Source: Shutterstock

More from Executives On The Move

More from Leadership